Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$379M |
| 2 |
Starbucks
SBUX
|
+$371M |
| 3 |
APC
Anadarko Petroleum
APC
|
+$287M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$263M |
| 5 |
Tesla
TSLA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
ANDV
Andeavor
ANDV
|
+$1.11B |
| 3 |
AET
Aetna Inc
AET
|
+$535M |
| 4 |
Microsoft
MSFT
|
+$350M |
| 5 |
Amazon
AMZN
|
+$290M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.69% |
| 2 | Technology | 13.64% |
| 3 | Financials | 12.49% |
| 4 | Consumer Discretionary | 10.83% |
| 5 | Industrials | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1076
Boise Cascade
BCC
$2.83B
| $10.9M | 0.02% |
457,602
+188,345
| +70% | +$5.41M |
|
|
VRS
1077
DELISTED
Verso Corporation
VRS
| $10.9M | 0.02% |
486,696
+193,948
| +66% | +$5.24M |
|
1078
Cheesecake Factory
CAKE
$5.65B
| $10.9M | 0.02% |
250,421
+211,810
| +549% | +$10.3M |
|
1079
Gentherm
THRM
$1.23B
| $10.9M | 0.02% |
271,724
+254,361
| +1,465% | +$10.8M |
|
1080
TherapeuticsMD
TXMD
$26.4M
| $10.9M | 0.02% |
56,975
+48,725
| +591% | +$11.9M |
|
1081
Applied Industrial Technologies
AIT
$12.3B
| $10.8M | 0.02% |
200,987
+54,412
| +37% | +$3.55M |
|
1082
Wabash National
WNC
$506M
| $10.8M | 0.02% |
828,288
+233,893
| +39% | +$3.45M |
|
1083
CALL
Rollins
ROL
$17.5B
| $10.8M | 0.02% |
+450,000
| New | +$11.6M |
|
1084
Viavi Solutions
VIAV
$9.3B
| $10.8M | 0.02% |
1,077,368
+176,819
| +20% | +$1.91M |
|
|
SNP
1085
DELISTED
CHINA PETROLEUM & CHEMICAL CORPORATION ADS (REP 100 ORDINARY H SHARES)
SNP
| $10.8M | 0.02% |
+152,558
| New | +$12.7M |
|
|
I
1086
CALL
DELISTED
INTELSAT S. A.
I
| $10.8M | 0.02% |
+503,500
| New | +$13.6M |
|
1087
Angi Inc
ANGI
$200M
| $10.7M | 0.02% |
66,776
+46,105
| +223% | +$8.36M |
|
|
MNK
1088
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $10.7M | 0.02% |
679,171
+240,682
| +55% | +$6M |
|
1089
CALL
United Airlines
UAL
$38.1B
| $10.7M | 0.02% |
128,000
+28,000
| +28% | +$2.46M |
|
1090
Cinemark Holdings
CNK
$4.34B
| $10.7M | 0.02% |
298,789
-142,052
| -32% | -$5.61M |
|
|
PINC
1091
DELISTED
Premier
PINC
| $10.7M | 0.02% |
285,617
-172,505
| -38% | -$7.13M |
|
1092
Progress Software
PRGS
$1.78B
| $10.7M | 0.02% |
300,215
+191,852
| +177% | +$6.4M |
|
1093
Macerich
MAC
$6.88B
| $10.6M | 0.02% |
245,321
-289,426
| -54% | -$14.3M |
|
|
STNLU
1094
DELISTED
Sentinel Energy Services Inc. Unit
STNLU
| $10.6M | 0.02% |
1,027,445
+277,445
| +37% | +$2.89M |
|
|
ITCI
1095
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $10.5M | 0.02% |
925,505
+381,508
| +70% | +$6.16M |
|
|
DCH
1096
Dauch Corp
DCH
$1.53B
| $10.5M | 0.02% |
946,335
-109,535
| -10% | -$1.46M |
|
1097
iShares MSCI Malaysia ETF
EWM
$321M
| $10.5M | 0.02% |
352,235
+271,508
| +336% | +$8.23M |
|
1098
PUT
Applied Materials
AMAT
$381B
| $10.5M | 0.02% |
320,200
-266,200
| -45% | -$9.13M |
|
1099
MillerKnoll
MLKN
$1.58B
| $10.5M | 0.02% |
345,970
+17,342
| +5% | +$577K |
|
1100
Onto Innovation
ONTO
$17.8B
| $10.5M | 0.02% |
382,588
-31,093
| -8% | -$959K |
|
Similar funds
Israel Englander's Q4 2018 Portfolio in Review
As of Q4 2018, Israel Englander held 4,541 positions worth $64.1B, down 21% from $81.6B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
Israel Englander withdrew a net $4.25B in Q4 2018, closing 844 positions and reducing 1,571 holdings. Its most notable exit was Andeavor, an estimated $1.11B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Athenahealth, Inc. worth $135M.
- Israel Englander's largest Q4 2018 buy was Athenahealth, Inc.: 1,022,505 shares worth $135M.
- Israel Englander added most to Celgene Corp in Q4 2018, an estimated $379M increase.
- Israel Englander's biggest Q4 2018 reduction was Fortive, cutting an estimated $1.27B.
- Israel Englander fully exited Andeavor in Q4 2018, selling an estimated $1.11B.
- Israel Englander's ten largest holdings make up 6.7% of its $64.1B portfolio in Q4 2018.
- Israel Englander opened 702 new positions and closed 844 in Q4 2018.
- Israel Englander's portfolio value fell 21% quarter-over-quarter to $64.1B.
Based on Millennium Management's 13F filing for Q4 2018, filed 14 Feb 2019.